<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title-group><journal-title>bioRxiv</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39713405</article-id><article-id pub-id-type="pmc">PMC11661271</article-id>
<article-id pub-id-type="doi">10.1101/2024.12.09.627470</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>DNA duplication-mediated activation of a two-component regulatory system serves as a bet-hedging strategy for <italic toggle="yes">Burkholderia thailandensis</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7602-033X</contrib-id><name><surname>Lowrey</surname><given-names>Lillian C.</given-names></name><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0003-1016-6282</contrib-id><name><surname>Mote</surname><given-names>Katlyn B.</given-names></name><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3726-3990</contrib-id><name><surname>Cotter</surname><given-names>Peggy A.</given-names></name><xref rid="CR1" ref-type="corresp">#</xref></contrib><aff id="A1">Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, USA</aff></contrib-group><author-notes><fn fn-type="equal" id="FN1"><label>*</label><p id="P1">These authors contributed equally to this work</p></fn><corresp id="CR1"><label>#</label>Address correspondence to Peggy A. Cotter, <email>pcotter@med.unc.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>12</month><year>2024</year></pub-date><elocation-id>2024.12.09.627470</elocation-id><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</ext-link>, which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.</license-p></license></permissions><self-uri content-type="pdf">nihpp-2024.12.09.627470.pdf</self-uri><abstract id="ABS1"><p id="P2"><italic toggle="yes">Burkholderia thailandensis</italic> strain E264 (<italic toggle="yes">Bt</italic>E264) and close relatives stochastically duplicate a 208.6 kb region of chromosome I via RecA-dependent recombination between two nearly identical insertion sequence elements. Because homologous recombination occurs at a constant, low level, populations of <italic toggle="yes">Bt</italic>E264 are always heterogeneous, but cells containing two or more copies of the region (Dup+) have an advantage, and hence predominate, during biofilm growth, while those with a single copy (Dup&#x02212;) are favored during planktonic growth. Moreover, only Dup+ bacteria form &#x02018;efficient &#x02018; biofilms within 24 hours in liquid medium. We determined that duplicate copies of a subregion containing genes encoding an archaic chaperone-usher pilus (<italic toggle="yes">aplFABCDE</italic>) and a two-component regulatory system (<italic toggle="yes">bubSR</italic>) are necessary and sufficient for generating efficient biofilms and for conferring a selective advantage during biofilm growth. BubSR functionality is required, as deletion of either <italic toggle="yes">bubS</italic> or <italic toggle="yes">bubR</italic>, or a mutation predicted to abrogate phosphorylation of BubR, abrogates biofilm formation. However, duplicate copies of the <italic toggle="yes">aplFABCDE</italic> genes are not required. Instead, we found that BubSR controls expression of <italic toggle="yes">aplFABCDE</italic> and <italic toggle="yes">bubSR</italic> by activating a promoter upstream of <italic toggle="yes">aplF</italic> during biofilm growth or when the 208.6 kb region, or just <italic toggle="yes">bubSR</italic>, are duplicated. Single cell analyses showed that duplication of the 208.6 kb region is sufficient to activate BubSR in 75% of bacteria during planktonic (BubSR &#x02018;OFF&#x02019;) growth conditions. Together, our data indicate that the combination of deterministic two-component signal transduction and stochastic, duplication-mediated activation of that TCS form a bet-hedging strategy that allows <italic toggle="yes">Bt</italic>E264 to survive when conditions shift rapidly from those favoring planktonic growth to those requiring biofilm formation, such as may be encountered in the soils of Southeast Asia and Northern Australia. Our data highlight the positive impact that transposable elements can have on the evolution of bacterial populations.</p></abstract><abstract id="ABS2" abstract-type="summary"><title>Author summary</title><p id="P3">Transposable elements naturally accumulate within genomes in all kingdoms of life. When present in the same orientation, a pair of homologous elements can act as substrates for DNA recombination reactions that can duplicate and delete intervening sequences &#x02013; giving rise to genetically heterogenous populations. We showed here that <italic toggle="yes">Burkholderia thailandensis</italic> strain E264 uses this mechanism to amplify genes encoding a two-component regulatory system and an archaic chaperone usher pilus, priming the cells for rapid biofilm formation. The formation of a small subpopulation of biofilm-ready bacteria serves as a bet-hedging strategy, ensuring overall population survival should conditions change rapidly from those in which planktonic growth is optimal to those in which adherence and biofilm formation is required.</p></abstract></article-meta></front><body><sec id="S1"><title>Introduction</title><p id="P4"><italic toggle="yes">Burkholderia thailandensis</italic> is a saprophytic environmental bacterium native to tropical regions of Northern Australia and Southeastern Asia (<xref rid="R1" ref-type="bibr">1</xref>). <italic toggle="yes">B. thailandensis</italic> has evolved to survive in aquatic and soil environments, such as rice paddies, where it must adapt to fluctuations in environmental conditions and compete with other microbes.</p><p id="P5">As is true for organisms in all kingdoms of life, <italic toggle="yes">B. thailandensis</italic> has accumulated insertion sequences and transposons &#x02013; parasitic genetic elements capable of moving between DNA sequences &#x02013; throughout its genome (<xref rid="R2" ref-type="bibr">2</xref>). In <italic toggle="yes">B. thailandensis</italic> strain E264 (<italic toggle="yes">Bt</italic>E264) and close relatives, two nearly identical IS<italic toggle="yes">2</italic>-like elements, IS&#x003b1; and IS&#x003b2;, bound a 208.6 kb region of DNA in chromosome I (hereafter referred to as &#x02018;the 208.6 kb region&#x02019;) (<xref rid="R3" ref-type="bibr">3</xref>). We recently discovered that these IS elements act as substrates for RecA-dependent homologous recombination that occurs during replication to produce tandem duplications of the 208.6 kb region (<xref rid="R4" ref-type="bibr">4</xref>). Reciprocally, homologous recombination between any of the duplicated 208.6 kb sequences in the tandem repeats can resolve the region back down to a single copy (<xref rid="R4" ref-type="bibr">4</xref>). Because these recombination reactions occur at a low but constant level, <italic toggle="yes">Bt</italic>E264 populations are consistently heterogeneous, composed of cells with (Dup+) and without (Dup&#x02212;) duplicate copies of the 208.6 kb region (<xref rid="R4" ref-type="bibr">4</xref>).</p><p id="P6">Amplification of DNA sequences (increasing gene dosage) can alter cell phenotypes (<xref rid="R5" ref-type="bibr">5</xref>). A well-studied example is increased antibiotic resistance, which can occur by amplification of genes encoding antibiotic targets, eblux pumps, or antibiotic-modifying enzymes (<xref rid="R6" ref-type="bibr">6</xref>). Copy number of the 208.6 kb region influences phenotypes in <italic toggle="yes">Bt</italic>E264, impacting colony morphology, pigmentation, and most notably, the rate of biofilm formation (<xref rid="R4" ref-type="bibr">4</xref>). While Dup&#x02212; and Dup+ <italic toggle="yes">Bt</italic>E264 can form visible biofilms on the sides on plastic culture tubes after multiple days of growth in M63 minimal medium, only Dup+ cells form visible biofilms at 24 hours post-inoculation &#x02013; a rapid form of biofilm formation that we refer to as efficient biofilms (<xref rid="R4" ref-type="bibr">4</xref>). Additionally, Dup+ cells have a competitive advantage in biofilms, whereas Dup&#x02212; cells have a competitive advantage during planktonic growth (<xref rid="R4" ref-type="bibr">4</xref>). We previously posited that the generation of Dup+ and Dup&#x02212; subpopulations is a bet-hedging strategy that allows <italic toggle="yes">Bt</italic>E264 to survive in unpredictable environments that quickly switch between those favoring biofilm or planktonic lifestyles (<xref rid="R4" ref-type="bibr">4</xref>).</p><p id="P7">The 208.6 kb region contains 158 predicted genes. We hypothesized that increasing the dosage of one or more of these genes leads to efficient biofilm formation. Our goals were to identify which gene(s) within the 208.6 kb region, when duplicated, confer this efficient biofilm phenotype, and to investigate the underlying mechanism.</p></sec><sec id="S2"><title>Results</title><sec id="S3"><title>Duplicate copies of DNA containing genes predicted to encode an archaic-type chaperone-usher pilus, a small hypothetical protein, and a two-component regulatory system are sufficient to promote efficient biofilm formation</title><p id="P8">To identify the gene(s) responsible for efficient biofilm formation, we first divided the 208.6 kb region into nine subregions (<xref rid="F1" ref-type="fig">Figure 1A</xref>), cloning each onto a plasmid using a modified plasmid rescue technique (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figures 1</xref> &#x00026; <xref rid="SD1" ref-type="supplementary-material">2</xref>). Briefly, we integrated a pair of I-<italic toggle="yes">Sce</italic>I restriction endonuclease site-containing suicide plasmids into the chromosome at the boundaries of each subregion, then isolated genomic DNA from each strain, digested the DNA with I-<italic toggle="yes">Sce</italic>I, ligated the isolated DNA, and transformed <italic toggle="yes">E. coli</italic>, selecting for kanamycin resistance (Km<sup>R</sup>). The composition and integrity of the resulting plasmids were confirmed by DNA sequence analysis. We then introduced each subregion-containing suicide plasmid into separate <italic toggle="yes">Bt</italic>E264 strains lacking IS&#x003b2; (&#x00394;IS&#x003b2;) (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 3</xref>), which were therefore unable to duplicate the entire 208.6 kb region, resulting in strains in which only a single subregion was duplicated. We tested each strain for its ability to form biofilms after 24 hours growth in M63 medium. Only the strain with a duplicate copy of subregion 4 formed efficient biofilms (<xref rid="F1" ref-type="fig">Figure 1A</xref>), indicating that the gene(s) sufficient for promoting efficient biofilm formation when present in multiple copies is/are within subregion 4.</p><p id="P9">Subregion 4 contains fourteen genes (<xref rid="F1" ref-type="fig">Figure 1B</xref>). Thirteen predicted genes are annotated in the reference genome: one H-NS histone family protein, one hydrolase, one major facilitator family transporter, one LysR family transcriptional regulator, one protein of unknown function, six comprising an archaic-type chaperone-usher pilus system, one hypothetical protein, and two encoding a two-component regulatory system (TCS). Closer investigation of subregion 4 revealed an additional ORF between the pilus- and TCS-encoding operons that is oriented in the opposite direction and has the potential to encode a small protein of unknown function. We divided subregion 4 into five sub-subregions (<xref rid="F1" ref-type="fig">Figure 1B</xref>), constructed suicide plasmids containing a single sub-subregion, and introduced these plasmids into the &#x00394;IS&#x003b2; strain. Strains with a duplicate copy of sub-subregion 4.4 or 4.5 formed a minimal biofilm, but neither fully phenocopied the level of biofilm formed by strains with a duplication of the full 208.6 kb region or a duplication of subregion 4. However, integration of a plasmid containing both sub-subregions 4.4 and 4.5 together (sub-subregion 4.4&#x02013;5), resulted in a strain that formed efficient biofilms (<xref rid="F1" ref-type="fig">Figure 1B</xref>). We named the genes in sub-subregion 4.4&#x02013;5 <italic toggle="yes">aplFABCDE</italic> for archaic pilus gene cluster, <italic toggle="yes">iou</italic> for intergenic orf of unknown function, and <italic toggle="yes">bubSR</italic> for <italic toggle="yes">Burkholderia</italic> biofilm sensor and regulator. Our data indicate that duplicate copies of the subregion of DNA containing these genes is sufficient for generating the efficient biofilm phenotype.</p></sec><sec id="S4"><title><italic toggle="yes">aplFABCDE</italic> and <italic toggle="yes">bubSR</italic>, but not <italic toggle="yes">iou</italic>, are required for efficient biofilm formation</title><p id="P10">We described previously the development of &#x02018;fragmented gene&#x02019; reporter strains, in which we replaced the IS<italic toggle="yes">2</italic>-like elements bounding the 208.6 kb region with a pair of incomplete, overlapping reporter gene fragments (<xref rid="R4" ref-type="bibr">4</xref>). The fragment replacing IS&#x003b1; is missing the 5&#x002b9; end of the reporter gene and the fragment replacing IS&#x003b2; is missing the 3&#x002b9; end of the reporter gene. Homologous recombination within the overlapping central part of the gene fragments results in duplication of the region and, a functional copy of the reporter gene (conferring antibiotic resistance, fluorescence, or the production of &#x003b2;-glucuronidase) present at the junction between the two duplicated regions (<xref rid="R4" ref-type="bibr">4</xref>). These reporters allow us to select or screen for bacteria containing a duplication of the intervening sequences.</p><p id="P11">To determine if <italic toggle="yes">aplFABCDE, iou</italic>, or <italic toggle="yes">bubSR</italic> are required for efficient biofilm formation, we used the fragmented <italic toggle="yes">nptII</italic> (encoding kanamycin resistance (Km<sup>R</sup>)) reporter strain (<xref rid="F2" ref-type="fig">Figure 2A</xref>). To mutate <italic toggle="yes">aplFABCDE</italic>, <italic toggle="yes">iou</italic>, and/or <italic toggle="yes">bubSR</italic>, we replaced them with <italic toggle="yes">dhfRII</italic> (encoding trimethoprim resistance (Tmp<sup>R</sup>)) in the fragmented <italic toggle="yes">nptII</italic> reporter strain, using bacteria that were Km<sup>S</sup> and hence contained only a single copy of the region. We then selected Km<sup>R</sup> derivatives (in which the region had duplicated) and compared Dup&#x02212; (Km<sup>S</sup>) and Dup+ (Km<sup>R</sup>) bacteria for their ability to form efficient biofilms. The wild-type bacteria and the <italic toggle="yes">iou</italic> mutant formed similar biofilms after 24 hours, while the <italic toggle="yes">aplFABCDE</italic> and <italic toggle="yes">bubSR</italic> mutants failed to form biofilms (<xref rid="F2" ref-type="fig">Figure 2B</xref>), indicating that <italic toggle="yes">aplFABCDE</italic> and <italic toggle="yes">bubSR</italic>, but not <italic toggle="yes">iou</italic>, are required for efficient biofilm formation.</p></sec><sec id="S5"><title><italic toggle="yes">aplFABCDE</italic> and <italic toggle="yes">bubSR</italic> are sufficient and required for duplication to provide a selective advantage during biofilm growth</title><p id="P12">We tested the hypothesis that <italic toggle="yes">aplFABCDE</italic> and <italic toggle="yes">bubSR</italic> are responsible for the selective advantage conferred by duplication of the 208.6 kb region during biofilm growth using our fragmented <italic toggle="yes">gusA</italic> (encoding b-glucuronidase) reporter system. With this system, Dup+ (<italic toggle="yes">gusA</italic><sup>+</sup>) bacteria form blue colonies when plated on medium containing X-gluc. We replaced <italic toggle="yes">aplFABCDE, iou</italic>, and/or <italic toggle="yes">bubSR</italic> with <italic toggle="yes">dhfRII</italic> in Dup&#x02212; fragmented <italic toggle="yes">gusA</italic> reporter bacteria then grew these strains to develop dynamic biofilms, replacing the liquid medium (and any cells it contained) every day with fresh, sterile medium. Throughout the experiment, mutants dibered in their ability to form biofilms on the sides of the culture tube (<xref rid="F3" ref-type="fig">Figure 3A</xref>). Wild-type and &#x00394;<italic toggle="yes">iou</italic> strains formed visible biofilms within two days that increased in robustness as the experiment progressed. Meanwhile, &#x00394;<italic toggle="yes">aplFABCDE</italic>::<italic toggle="yes">dhfRII</italic>, &#x00394;<italic toggle="yes">bubSR</italic>::<italic toggle="yes">dhfRII</italic>, and &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic> strains were unable to form robust biofilms, and only formed minimal clumpy and nonuniform aggregations on the sides of the culture tube late into the experiment, which looked considerably different than the biofilms formed by wild-type and &#x00394;<italic toggle="yes">iou</italic>::<italic toggle="yes">dhfRII</italic> bacteria. These data show that <italic toggle="yes">aplFABCDE</italic> and <italic toggle="yes">bubSR</italic> are not only required for efficient biofilm formation, but they are also required for longer-term &#x02018;in efficient &#x02018; biofilm formation as well.</p><p id="P13">When sampling from the biofilms (wild-type and &#x00394;<italic toggle="yes">iou::dhfRII</italic> strains)<italic toggle="yes">,</italic> we observed that within two days, nearly 25% of the population formed blue colonies on X-Gluc-containing medium, indicating that a quarter of the biofilm was composed of Dup+ cells (<xref rid="F3" ref-type="fig">Figure 3B</xref>). At three days and longer, the percentage of blue colonies, and thus Dup+ cells, was nearly 50%. These data are consistent with those we reported for wild-type <italic toggle="yes">Bt</italic>E264 previously (<xref rid="R4" ref-type="bibr">4</xref>). These data indicate that <italic toggle="yes">iou</italic> is not required for the advantage that duplication of the region provides during biofilm growth (<xref rid="F3" ref-type="fig">Figure 3B</xref>). For the &#x00394;<italic toggle="yes">aplFABCDE</italic>::<italic toggle="yes">dhfRII</italic>, &#x00394;<italic toggle="yes">bubSR</italic>::<italic toggle="yes">dhfRII</italic>, and &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic> strains, nearly all the colonies obtained from the scant &#x02018;biofilms&#x02019; that formed were white on X-Gluc-containing medium, indicating that they were Dup&#x02212;. a<italic toggle="yes">plFABCDE</italic> and <italic toggle="yes">bubSR,</italic> therefore, are required for the selective advantage conferred by duplication of the region during dynamic biofilm growth.</p><p id="P14">To determine if duplication of the <italic toggle="yes">aplFABCDE,iou,bubSR</italic> gene cluster is sufficient to confer the selective advantage, i.e., none of the remaining 149 genes within the 208.6 kb region are required, we generated a &#x02018;reduced&#x02019; fragmented <italic toggle="yes">gusA</italic> reporter strain wherein we inserted the <italic toggle="yes">gusA</italic> gene fragments immediately flanking the <italic toggle="yes">aplFABCDE,iou,bubSR</italic>, genes (<xref rid="F3" ref-type="fig">Figure 3C</xref>). When serially passaged to select for dynamic biofilm formation, the level and quality of biofilm formation mirrored that of the strain with <italic toggle="yes">gusA</italic> fragments at IS&#x003b1; and IS&#x003b2; (<xref rid="F3" ref-type="fig">Figure 3A</xref>). Similarly, when sampling from the biofilm, the proportion of blue colonies increased and plateaued at nearly 50% after three days (<xref rid="F3" ref-type="fig">Figure 3D</xref>). These data indicate that duplication of the <italic toggle="yes">aplFABCDE,iou,bubSR</italic> gene cluster is sufficient for providing the selective advantage during biofilm growth.</p></sec><sec id="S6"><title>BubSR TCS activity is required for efficient biofilm formation</title><p id="P15">Analysis of the predicted amino acid sequence of BubS with SMART domain prediction and AlphaFold2 reveals that BubS is likely an unorthodox histidine kinase (i.e., it contains a histidine kinase domain, a receiver domain, and a histidine phosphotransfer domain) (<xref rid="F4" ref-type="fig">Figure 4A</xref>). It is unusual in that it contains no obvious sensory input domain. Histidine Kinase A (dimerization/phosphoacceptor) (HisKA) (BubS<sub>A84 &#x02013; G149</sub>) and Histidine Kinase-like ATPase (HATPase) (BubS<sub>T196-V312</sub>) domains were identified by SMART, and the predicted phosphorylation site is H94. A CheY-similar Receiver (REC) domain (BubS<sub>Y436-L551</sub>) was also predicted by SMART, with conserved aspartic acid residues D442, D443, and D486: D486 being the site of phosphorylation. No Histidine Phosphotransfer (HPt) domain was predicted by SMART, but AlphaFold2 analysis of the C-terminal 150 amino acids of BubS (BubS<sub>E556-S680</sub>) revealed a high-confidence structure that resembles the Hpt of the <italic toggle="yes">Escherichia coli</italic> unorthodox histidine kinase BarA (<xref rid="F4" ref-type="fig">Figure 4B</xref> and <xref rid="F4" ref-type="fig">C</xref>).</p><p id="P16">SMART predicted REC and LuxR-type Helix-turn-helix DNA binding (HTH) domains in BubR, indicating that BubR belongs in the NarL/FixJ family. The BubR REC domain likely coordinates the phosphoryl group at residues D9, D10, and D55, with D55 as the site of phosphorylation.</p><p id="P17">To determine if BubSR TCS activity is required for Dup+ cells to produce efficient biofilms, we used allelic exchange in a fragmented <italic toggle="yes">nptII</italic> reporter strain to delete <italic toggle="yes">bubS</italic> or <italic toggle="yes">bubR</italic> or to change codon 55 in <italic toggle="yes">bubR</italic> such that it encodes alanine instead of aspartic acid (BubR<sub>D55A</sub>), which should prevent phosphorylation of BubR. All three mutations, regardless of copy number of the region, abrogated the ability of the bacteria to form efficient biofilms (<xref rid="F4" ref-type="fig">Figure 4D</xref>), indicating that BubSR activity is required for efficient biofilm formation.</p></sec><sec id="S7"><title>Two copies of <italic toggle="yes">bubSR</italic> plus the intergenic region 5&#x002b9; to <italic toggle="yes">aplFABCDE</italic> are sufficient to promote efficient biofilm formation</title><p id="P18">Because wild-type <italic toggle="yes">Bt</italic>E264 and <italic toggle="yes">bubSR</italic> mutants are indistinguishable when grown planktonically in M63 medium, but only wild-type (not <italic toggle="yes">bubSR</italic> mutant) bacteria can form biofilms (either in 24 hours for Dup+ bacteria or four days for Dup-bacteria), we reasoned that planktonic growth in M63 medium is likely a condition in which the BubSR TCS is inactive, and biofilm growth is likely a condition in which BubSR is active. We hypothesized that <italic toggle="yes">bubSR</italic> is positively autoregulated and that active BubR (i.e., phosphorylated BubR (BubR~P)) also activates transcription of the <italic toggle="yes">aplFABCDE</italic> genes, which are also required for biofilm formation. Moreover, we hypothesized that two copies of <italic toggle="yes">bubSR</italic> causes the level of BubR~P in at least some bacteria growing planktonically in M63 to be above the threshold needed for positive autoregulation. To test this hypothesis, we cloned <italic toggle="yes">bubSR</italic> plus the intergenic region between <italic toggle="yes">aplE</italic> and <italic toggle="yes">bubS</italic> (the putative promoter region for <italic toggle="yes">bubSR</italic>) into plasmid pUC18-miniTn7-Km and delivered the resulting plasmid into a &#x00394;<italic toggle="yes">bubSR::dhfRII</italic> &#x00394;IS&#x003b1; strain by conjugation. Because <italic toggle="yes">B. thailandensis</italic> E264 contains two <italic toggle="yes">glmS</italic> genes, we could obtain strains containing <italic toggle="yes">bubSR</italic> (and the 3&#x002b9; adjacent <italic toggle="yes">nptII</italic> gene, which is not shown in the figure) inserted at either one or both <italic toggle="yes">att</italic>Tn<italic toggle="yes">7</italic> sites (<xref rid="F5" ref-type="fig">Figure 5A</xref>). Unexpectedly, the strain containing two copies of <italic toggle="yes">bubSR</italic> (one at each <italic toggle="yes">att</italic>Tn<italic toggle="yes">7</italic> site) did not form efficient biofilms (<xref rid="F5" ref-type="fig">Figure 5A</xref>). We next cloned the region containing the entire <italic toggle="yes">aplFABCDE,iou,bubSR</italic> locus, including the intergenic region 5&#x002b9; to <italic toggle="yes">aplF,</italic> into plasmid pUC18-miniTn7-Km and selected strains in which the <italic toggle="yes">aplFABCDE,iou,bubSR</italic> (and <italic toggle="yes">nptII</italic>, not shown<italic toggle="yes">)</italic>-containing cassette was present at one or both <italic toggle="yes">att</italic>Tn7 sites in a &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic> &#x00394;IS&#x003b1; strain (<xref rid="F5" ref-type="fig">Figure 5B</xref>). Only the strain containing two copies of the <italic toggle="yes">aplFABCDE,iou,bubSR</italic> locus formed an efficient biofilm (<xref rid="F5" ref-type="fig">Figure 5B</xref>). It seemed unlikely to us that two copies of <italic toggle="yes">aplFABCDE</italic> are required for efficient biofilm formation. Instead, we hypothesized that the promoter required for activating transcription of <italic toggle="yes">bubSR</italic> is located 5&#x002b9; to <italic toggle="yes">aplF</italic>. To test this hypothesis, we constructed a plasmid containing the entire <italic toggle="yes">aplFABCDE,iou,bubSR</italic> locus but with a large deletion extending from <italic toggle="yes">aplF</italic> to <italic toggle="yes">aplE,</italic> and delivered the plasmid to the &#x00394;<italic toggle="yes">bubSR::dhfRII</italic> &#x00394;IS&#x003b1; strain by conjugation (<xref rid="F5" ref-type="fig">Figure 5C</xref>). Surprisingly, even the strain with the <italic toggle="yes">aplF</italic>&#x002b9;&#x02212;&#x002b9;<italic toggle="yes">aplE,iou,bubSR-</italic>containing cassette at only one <italic toggle="yes">att</italic>Tn<italic toggle="yes">7</italic> site formed an efficient biofilm (<xref rid="F5" ref-type="fig">Figure 5C</xref>). These results indicate that two copies of the <italic toggle="yes">aplFABCDE</italic> genes are not required for efficient biofilm formation, and they suggest that a promoter required for activation of both <italic toggle="yes">aplFABCDE</italic> and <italic toggle="yes">bubSR</italic> expression is located in the intergenic region 5&#x002b9; to <italic toggle="yes">aplF</italic>. The data also suggest that sequences within the <italic toggle="yes">aplFABCDE</italic> genes somehow negatively influence <italic toggle="yes">bubSR</italic> expression.</p></sec><sec id="S8"><title>The intergenic region 5&#x002b9; to <italic toggle="yes">aplF</italic>, but not the region between <italic toggle="yes">aplE</italic> and <italic toggle="yes">bubS</italic>, contains a promoter that is activated during biofilm growth and when the 208.6 kb region is duplicated, in a <italic toggle="yes">bubSR</italic>-dependent manner</title><p id="P19">To determine directly if the regions 5&#x002b9; to <italic toggle="yes">aplF</italic> and <italic toggle="yes">bubS</italic> contain promoters that are activated when the 208.6 kb region is duplicated and/or during biofilm growth, we cloned each putative promoter region (P<sub><italic toggle="yes">apl</italic></sub> and P<sub><italic toggle="yes">bub</italic></sub>, <xref rid="F6" ref-type="fig">Figure 6A</xref>) 5&#x002b9; to the <italic toggle="yes">gfp</italic> gene that was codon-optimized for <italic toggle="yes">B. thailandensis</italic> in plasmid pKBM19 (creating pKBM21 and pKBM20, respectively), and delivered the P<sub><italic toggle="yes">apl</italic></sub><italic toggle="yes">-gfp</italic> and P<sub><italic toggle="yes">bub</italic></sub><italic toggle="yes">-gfp</italic> cassettes to <italic toggle="yes">att</italic>Tn<italic toggle="yes">7</italic> (selecting those with only a single copy at the <italic toggle="yes">glmS1</italic>site) in wild-type and <italic toggle="yes">bubSR</italic> mutant strains containing either a deletion of IS&#x003b1; (Dup&#x02212; locked bacteria) or the fragmented <italic toggle="yes">nptII</italic> genes (to select for Dup+ bacteria). For the resulting GFP reporter strains, we grew cultures wherein spent medium was replaced with fresh M63 every 24 hours. Planktonic and biofilm bacteria were collected after 24- or 96-hours growth in M63 medium, washed, fixed, and transferred to a 96-well plate to measure fluorescence intensity.</p><p id="P20">Planktonically grown cells containing the P<sub><italic toggle="yes">apl</italic></sub><italic toggle="yes">-gfp</italic> fusion produced a low level of fluorescence (92 RFI units) when the 208.6 kb region was present in a single copy after 24 hours growth in M63. By contrast, when the 208.6 kb region was duplicated, the level of fluorescence in bacteria growing planktonically was 1,436 RFI units, a 15.6-fold increase compared to Dup&#x02212; bacteria (<xref rid="F6" ref-type="fig">Figure 6B</xref>). When Dup+ bacteria containing the P<sub><italic toggle="yes">apl</italic></sub><italic toggle="yes">-gfp</italic> fusion were recovered from the biofilm after 24 hours growth, the level of fluorescence was 1,909 RFI units (<xref rid="F6" ref-type="fig">Figure 6B</xref>). Fluorescence of <italic toggle="yes">bubS</italic> or <italic toggle="yes">bubR</italic> mutants containing the P<sub><italic toggle="yes">apl</italic></sub><italic toggle="yes">-gfp</italic> fusion was at background levels under all conditions (<xref rid="F6" ref-type="fig">Figure 6B</xref>), confirming that activation of P<sub><italic toggle="yes">apl</italic></sub> requires active BubSR.</p><p id="P21">In Dup&#x02212; bacteria containing the P<sub><italic toggle="yes">apl</italic></sub><italic toggle="yes">-gfp</italic> fusion grown for 96 hours, the level of fluorescence was 237 RFI units in the planktonic bacteria and 403 RFI units in the bacteria recovered from the biofilm (<xref rid="F6" ref-type="fig">Figure 6C</xref>).</p><p id="P22">Strains containing the P<sub><italic toggle="yes">bub</italic></sub><italic toggle="yes">-gfp</italic> fusion produced no fluorescence under any condition, confirming that the region 5&#x002b9; to <italic toggle="yes">bubS</italic> does not contain a promoter that is active under any of the growth conditions tested (<xref rid="F6" ref-type="fig">Figure 6C</xref>).</p><p id="P23">These data show that there is a promoter 5&#x002b9; to <italic toggle="yes">aplF</italic> and that its expression increases dramatically, in a BubSR-dependent manner, when the 208.6 kb region is duplicated, suggesting that <italic toggle="yes">bubSR</italic> is positively autoregulated via P<sub><italic toggle="yes">apl</italic></sub>. P<sub><italic toggle="yes">apl</italic></sub> is also activated during biofilm growth in Dup&#x02212; bacteria, although not as strongly as in Dup+ bacteria.</p></sec><sec id="S9"><title>Duplication of <italic toggle="yes">bubSR</italic> is sufficient to activate P<sub><italic toggle="yes">apl</italic></sub> in a majority of bacteria growing in M63 medium</title><p id="P24">The plate reader (data shown in <xref rid="F6" ref-type="fig">Figure 6</xref>) measures total fluorescence in each population of bacteria. To measure fluorescence, and hence P<sub><italic toggle="yes">apl</italic></sub> and P<sub><italic toggle="yes">bub</italic></sub> expression, in single cells, we analyzed aliquots of the same cultures using flow cytometry. We stained the samples with SYTO 61 to identify cells and to exclude any debris and electronic background. Next, we used forward and side scatter to gate for single bacterial cells and measured the GFP fluorescence of particles contained within these parameters. The level of fluorescence for all bacteria containing the P<sub><italic toggle="yes">bub</italic></sub>-<italic toggle="yes">gfp</italic> fusion was very low (<xref rid="F7" ref-type="fig">Figure 7B</xref>), as expected. For most Dup&#x02212; planktonic bacteria containing the P<sub><italic toggle="yes">apl</italic></sub><italic toggle="yes">-gfp</italic> fusion, the level of fluorescence was also very low, similar to that of bacteria containing the P<sub><italic toggle="yes">bub</italic></sub>-<italic toggle="yes">gfp</italic> fusion (<xref rid="F7" ref-type="fig">Figure 7C</xref>, green curve). However, the level of fluorescence was higher in ~6% of these bacteria and was quite high in a very small number of bacteria (<xref rid="F7" ref-type="fig">Figure 7C</xref>, shoulder of green curve). These data are consistent with planktonic growth corresponding to a BubSR-inactive condition, with a small proportion of bacteria stochastically producing enough BubR~P to activate P<sub><italic toggle="yes">apl</italic></sub>, and hence cause positive autoregulation of <italic toggle="yes">bubSR</italic>.</p><p id="P25">For Dup+ planktonic bacteria containing the P<sub><italic toggle="yes">apl</italic></sub><italic toggle="yes">-gfp</italic> fusion, two distinct populations were apparent (<xref rid="F7" ref-type="fig">Figure 7D</xref>, cyan curve): 24.7% of the population was essentially non-fluorescent and 75.3% of the population was highly fluorescent, indicating that two copies of <italic toggle="yes">bubSR</italic> is sufficient for activation of P<sub><italic toggle="yes">apl</italic></sub> &#x02013; and hence also <italic toggle="yes">bubSR</italic> &#x02013; even under BubSR-inactivating conditions in most bacteria. Dup+ bacteria containing the P<sub><italic toggle="yes">apl</italic></sub><italic toggle="yes">-gfp</italic> fusion collected from the biofilm (<xref rid="F7" ref-type="fig">Figure 7D</xref>, pink graph) had an even higher proportion of highly fluorescent bacteria (85.6%). Dup&#x02212; bacteria containing the P<sub><italic toggle="yes">apl</italic></sub><italic toggle="yes">-gfp</italic> fusion collected after 96-hours growth displayed a range of fluorescence from low to moderate, with a slight shift towards increased fluorescence in bacteria collected from the biofilm compared to bacteria recovered from the liquid (<xref rid="F7" ref-type="fig">Figure 7E</xref>). Although very few of these bacteria were as fluorescent as Dup+ bacteria.</p><p id="P26">Together, these data suggest that planktonic growth in M63 medium is a condition in which the BubSR TCS is inactive, but that a small amount of BubR~P forms stochastically in a small proportion of bacteria under these conditions, and that this level of BubR~P is sufficient to activate P<sub><italic toggle="yes">apl</italic></sub>, and hence cause positive autoregulation of <italic toggle="yes">bubSR</italic>, which increases the amount of BubR~P in those cells even further. The data suggest further that simply doubling the copy number of <italic toggle="yes">bubSR</italic> causes the level of BubR~P that forms stochastically to be above the threshold required for activation of P<sub><italic toggle="yes">apl</italic></sub> in a majority (~75%) of bacteria.</p></sec></sec><sec id="S10"><title>Discussion</title><p id="P27">To persist, bacterial populations must adapt to ever-changing environmental conditions, and they frequently do so using two-component regulatory systems (TCS). Composed generally of a histidine kinase that senses environmental cues and, in response, phosphorylates a response regulator that effects a change in behavior (usually by activating and/or repressing gene expression), TCSs allow all members of a population to adapt appropriately, maximizing their fitness to a specific environmental condition (<xref rid="R7" ref-type="bibr">7</xref>). However, when facing unrecognizable stimuli, or when conditions fluctuate too rapidly for signal transduction systems to mount an appropriate response, bacterial populations may be unable to adapt. In these cases, bet-hedging strategies, wherein a subpopulation of bacteria stochastically exhibits a phenotype that is maladapted for the current condition but essential in another, may allow population survival (<xref rid="R8" ref-type="bibr">8</xref>). Bet-hedging can be accomplished by heritable and reversible genetic mutations that lead to stochastic switching between distinct phenotypes, a phenomenon known as phase variation (<xref rid="R9" ref-type="bibr">9</xref>). It can also be accomplished by unequal activation of signal transduction systems in genotypically homogenous bacterial populations, resulting in subpopulations that display phenotypes opposite to those dictated by the environmental condition (<xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref>).</p><p id="P28">We showed in this study that a combination of these two strategies &#x02013; deterministic two-component signal transduction and stochastic, duplication-mediated activation of that TCS &#x02013; underlies efficient biofilm formation in <italic toggle="yes">B. thailandensis</italic> E264. Our data showing that <italic toggle="yes">bubSR</italic> mutants are indistinguishable from wild-type bacteria during planktonic growth and are unable to form biofilms strongly suggest that the BubSR TCS is inactive during planktonic growth in M63 liquid medium and active during biofilm growth. This conclusion is supported by the promoter-<italic toggle="yes">gfp</italic> fusion data that indicate that in Dup&#x02212; bacteria growing planktonically, P<sub><italic toggle="yes">apl</italic></sub> expression, which is dependent on BubSR activity (and specifically BubR~P, as the BubR<sub>D55A</sub> mutant fails to activate P<sub><italic toggle="yes">apl</italic></sub>), is very low in ~94% of the bacteria. When Dup&#x02212; bacteria are recovered from the in efficient biofilm that ultimately forms, P<sub><italic toggle="yes">apl</italic></sub> expression is ~4-fold higher than in planktonic bacteria, indicating that BubSR is active in the biofilm. Thus, BubSR appears to mediate the deterministic response, controlling expression of at least two sets of genes (<italic toggle="yes">aplFABCDE</italic> and <italic toggle="yes">bubSR</italic>) that are required for biofilm growth, such that they are expressed under biofilm conditions and not during planktonic growth. Stochastic, RecA-dependent duplication of the 208.6 kb region provides the bet-hedging strategy; in 75% of Dup+ bacteria growing planktonically P<sub><italic toggle="yes">apl</italic></sub> expression was very high, indicating that simply doubling the amount of BubSR causes the level of BubR~P, under BubSR-inactivating conditions, to be above the threshold required to activate P<sub><italic toggle="yes">apl</italic></sub>, resulting in greatly increased expression of the <italic toggle="yes">aplFABCDE</italic> and <italic toggle="yes">bubSR</italic> genes<italic toggle="yes">.</italic> In wild-type bacteria growing planktonically (such as, perhaps, in flooded soil), the proportion of Dup+ bacteria is likely to be about one in ~10,000 (<xref rid="R4" ref-type="bibr">4</xref>), so even if 75% of those bacteria have an active BubSR TCS, the proportion of maladapted bacteria in the population will be very small. However, if conditions change rapidly such that biofilm growth is required, the small proportion of BubSR-active bacteria will survive, maintaining the lineage at that site. Thus, the bet-hedging strategy provided by RecA-dependent duplication of the 208.6 kb region may allow population survival when conditions shift from those favoring planktonic growth to those requiring biofilm growth too rapidly for a BubSR signal transduction-mediated response.</p><p id="P29">For TCSs to function, there must be sufficient sensor kinase and response regulator proteins in the cell under &#x02018;OFF&#x02019; conditions for the sensor kinase to be able to respond to &#x02018;ON&#x02019; conditions by autophosphorylating and transferring the phosphoryl group to, and thus activating, the response regulator, which, in many cases, causes positive autoregulation and amplification of the system. Simple enzyme kinetics would predict that even under &#x02018;OFF&#x02019; conditions, a small proportion of response regulator protein would be phosphorylated stochastically. Our data suggest that for BubSR, the proportion of planktonic bacteria after overnight growth in M63 with enough BubR~P to activate P<sub><italic toggle="yes">apl</italic></sub> is about 6%, which is higher than we would have predicted. Moreover, simply doubling <italic toggle="yes">bubSR</italic> copy number increased that proportion to ~75%. These data suggest that BubS activity may be just below an activation threshold when the bacteria are growing in M63 medium such that merely doubling the amount of BubS pushes the system over the threshold in most cells. The lack of obvious sensing domains makes predicting the signals to which BubS responds difficult. However, <italic toggle="yes">bubSR</italic> homologs have been identified in <italic toggle="yes">Burkholderia pseudomallei</italic> (<xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R13" ref-type="bibr">13</xref>), and there is evidence that <italic toggle="yes">bubSR</italic> (called <italic toggle="yes">bfmSR</italic> in <italic toggle="yes">B. pseudomallei</italic>) expression and BubSR (BfmSR) activity may increase under iron-limiting conditions (<xref rid="R14" ref-type="bibr">14</xref>). It is possible that after overnight growth in M63 medium, and maybe more so for bacteria accumulating on the walls of the test tube, iron and/or other nutrients are depleted, shifting the conditions towards those in which BubS is active. We will investigate this possibility in the future.</p><p id="P30">Comparisons between <italic toggle="yes">B. thailandensis</italic> and <italic toggle="yes">B. pseudomallei</italic> yielded additional insight. Although the amino acid sequences of BubS in <italic toggle="yes">Bt</italic>E264 and BfmS in <italic toggle="yes">B. pseudomallei</italic> K96243 are 90% identical and 92% similar, SMART predicts a transmembrane domain at the N-terminus of BfmS but not for BubS. As most sensor kinases are cytoplasmic membrane proteins, it is likely that BubS contains a trans-membrane domain that was not identified by SMART, but biochemical experiments will be required to determine if BubS (or BfmS) is membrane-localized. It is also noteworthy that although the intergenic sequences between <italic toggle="yes">aplFABCDE</italic> (<italic toggle="yes">B. thailandensis</italic>)/<italic toggle="yes">csuABCDE</italic> (<italic toggle="yes">B. pseudomallei</italic>) <italic toggle="yes">and bubS</italic> (<italic toggle="yes">B. thailandensis</italic>)<italic toggle="yes">/bfmS</italic> (<italic toggle="yes">B. pseudomallei</italic>) are nearly identical, a single additional nucleotide in the <italic toggle="yes">B. pseudomallei</italic> sequence abrogates the prediction of an ORF in this region. This information, together with the fact that <italic toggle="yes">iou</italic> is not required for either efficient or in efficient biofilm formation or for the selective advantage conferred by duplicating the 208.6 kb region during biofilm growth in <italic toggle="yes">Bt</italic>E264, suggests that <italic toggle="yes">iou</italic> may not encode a functional protein.</p><p id="P31">Genetic linkage between genes encoding regulatory proteins and the genes they control is common, and it is also common for TCSs to (also) regulate unlinked genes. While the full BubSR regulon is currently unknown, genes in addition to <italic toggle="yes">aplFABCDE</italic>, including those predicted to encode an exopolysaccharide, are required for biofilm formation (<xref rid="R15" ref-type="bibr">15</xref>). In a previous report from our group, we compared the transcriptomes of wild-type <italic toggle="yes">Bt</italic>E264 with those of strains in which expression of the <italic toggle="yes">bcpAOIB</italic> genes (encoding a contact-dependent inhibition system) was driven by the constitutive S12 promoter or that produced a catalytically inactive BcpA protein (<xref rid="R15" ref-type="bibr">15</xref>). We now know that these strains were predominantly Dup+ and Dup&#x02212;, respectively. Consistent with our current data, transcript abundance for the <italic toggle="yes">aplFABCDE</italic> and <italic toggle="yes">bubSR</italic> genes was dramatically increased in the strain with P<sub>S12</sub> driving <italic toggle="yes">bcpAIOB</italic> compared to the BcpA mutant, as were many others, including those predicted to encode an exopolysaccharide. However, because the 208.6 kb region contains several genes that are predicted to encode transcription regulators, additional experiments will be required to determine if any of the differentially-expressed genes identified in the previous study are controlled by BubSR.</p><p id="P32">In the current study, we focused on efficient biofilm formation, but other duplication-dependent phenotypes, such as Congo red binding and the production of a gold-brown pigment, exist (<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref>). We do not know, at this point, what genes are responsible for those phenotypes or whether they are regulated by BubSR. Indeed, these other phenotypes could require duplication of a different subregion within the 208.6 kb region. If these other duplication-dependent phenotypes are beneficial, it could explain the selective advantage for strains with IS&#x003b1; and IS&#x003b2; in their current locations. We showed in this work that duplication of only the <italic toggle="yes">aplFABCDE,iou,bubSR</italic> genes is sufficient for efficient biofilms to form and for the selective advantage conferred by duplication during biofilm growth. Since duplication of a smaller region would provide less homology for recombination-mediated loss of the duplication, it would seem to be more advantageous for IS&#x003b1; and IS&#x003b2; to be closer together. Are their current locations just chance, or is duplication of other genes within the 208.6 kb region advantageous under conditions that we have not yet explored? Continued investigation will be required to understand the depth and breadth of the stochastic, IS-mediated bet-hedging strategy in <italic toggle="yes">Bt</italic>E264.</p><p id="P33">Interplay between TCS signaling and phase variation is not uncommon. In many cases, phase variation removes one or more genes from the deterministic control of the TCS without altering the entire regulon. For example, phase variation-mediated mutation of genes encoding <italic toggle="yes">Helicobacter pylori</italic> adhesins and <italic toggle="yes">Neisseria meningitidis</italic> hemoglobin receptors, which are regulated by TCSs that control many genes required for infection, prevents production of these immunostimulatory proteins, thereby allowing the bacteria to evade the host immune system (<xref rid="R16" ref-type="bibr">16</xref>&#x02013;<xref rid="R20" ref-type="bibr">20</xref>). In other cases, phase variation toggles on or off production of the TCSs themselves, leading to two distinct subpopulations; phase variation-ON subpopulations that produce the TCS and are able to sense-and-respond to the recognized stimulus, and phase variation-OFF subpopulations that are effectively blind to the activating stimulus (<xref rid="R21" ref-type="bibr">21</xref>&#x02013;<xref rid="R26" ref-type="bibr">26</xref>). DNA duplication-mediated activation of BubSR represents another form of interplay between TCS signaling and phase variation, further highlighting the positive impact that transposable elements can have on the evolution of bacterial populations.</p></sec><sec id="S11"><title>Materials and Methods</title><sec id="S12"><title>Bacterial culture conditions</title><p id="P34"><italic toggle="yes">Bt</italic>E264 is an environmental isolate (<xref rid="R1" ref-type="bibr">1</xref>). Plasmids were maintained in <italic toggle="yes">E. coli</italic> DH5&#x003b1;. For insertion at the <italic toggle="yes">att</italic>Tn<italic toggle="yes">7</italic> sites or Flp-mediated FRT recombination, plasmids were introduced into <italic toggle="yes">Bt</italic>E264 by conjugation with <italic toggle="yes">E. coli</italic> donor strain, RHO3 (<xref rid="R27" ref-type="bibr">27</xref>). <italic toggle="yes">Bt</italic>E264 and <italic toggle="yes">E. coli</italic> strains were grown overnight with aeration at 37&#x000b0;C (unless indicated) in low-salt Luria-Bertani (LSLB, 0.5% NaCl). Antibiotics and supplements were added to cultures at the following concentrations: 50 &#x003bc;g/mL X-Gluc (5-bromo-4-chloro-3-indoxyl-beta-D-glucuronide), 200 &#x003bc;g/mL 2,6-diaminopimelic acid (DAP), 0.2% (wt/vol) rhamnose, 500 &#x003bc;g/mL (for <italic toggle="yes">Bt</italic>E264) or 50 &#x003bc;g/mL (for <italic toggle="yes">E. coli</italic>) kanamycin (Km), 100 &#x003bc;g/mL (for <italic toggle="yes">Bt</italic>E264) or 50 &#x003bc;g/mL (for <italic toggle="yes">E. coli</italic>) trimethoprim (Tmp), 50 &#x003bc;g/mL (for <italic toggle="yes">Bt</italic>E264) or 10 &#x003bc;g/mL (for <italic toggle="yes">E. coli</italic>) tetracycline (Tc), 100 &#x003bc;g/mL ampicillin (Ap), 200 &#x003bc;g/mL zeocin (Zeo), or 30 &#x003bc;g/mL (for <italic toggle="yes">Bt</italic>E264) chloramphenicol (Cm) as appropriate. Because trimethoprim exposure alters gene expression in <italic toggle="yes">Burkholderia thailandensis</italic>, trimethoprim was only used to select for stable mutations that do not require continuous selection, and experiments were conducted without trimethoprim (<xref rid="R28" ref-type="bibr">28</xref>). When indicated, <italic toggle="yes">Bt</italic>E264 was cultured in M63 minimal medium (110 mM KH<sub>2</sub>PO<sub>4</sub>, 200 mM K<sub>2</sub>HPO<sub>4</sub>, 75 mM (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 16 nM FeSO<sub>4</sub>) supplemented with 1 mM MgSO<sub>4</sub>, 0.2% glucose, 0.4% glycerol, and 0.01% casamino acids.</p></sec><sec id="S13"><title>Mutant construction techniques</title><sec id="S14"><title>Natural transformation</title><p id="P35">Linearized plasmids containing an antibiotic resistance-encoding gene flanked by ~500 bp sequences with homology to genomic regions of interest were introduced to <italic toggle="yes">Bt</italic>E264 following previously described protocols (<xref rid="R29" ref-type="bibr">29</xref>). Transformants were isolated on LSLB-supplemented with the appropriate antibiotic and verified through PCR analysis.</p></sec><sec id="S15"><title>Allelic exchange</title><p id="P36">Markerless mutations were constructed through allelic exchange with <italic toggle="yes">sacB</italic> counterselection. Plasmids with a pEXKm5 backbone were constructed to contain mutant DNA sequences with homology to the chromosome and subsequently introduced into <italic toggle="yes">E. coli</italic> RHO3. RHO3 were then mated with a <italic toggle="yes">Bt</italic>E264 strain of interest and transformants were isolated on LSLB-supplemented with the appropriate antibiotic. Allelic exchange was conducted using previously established protocols (<xref rid="R27" ref-type="bibr">27</xref>).</p></sec><sec id="S16"><title>Plasmid integration</title><p id="P37">Plasmids containing sequences of interest with homology to the genome were introduced into RHO3 and were subsequently mated into <italic toggle="yes">Bt</italic>E264, in which, the plasmid backbone could not replicate. Single homologous recombination between the chromosome and the introduced plasmid would integrate plasmid DNA onto the chromosome. Transformants were isolated on LSLB-supplemented with the appropriate antibiotic.</p></sec><sec id="S17"><title>Flp-FRT recombination</title><p id="P38">Flp-mediated FRT recombination was used to excise antibiotic cassettes flanked by FRT sequences. Recombination was conducted according to previously described protocols (<xref rid="R30" ref-type="bibr">30</xref>).</p></sec><sec id="S18"><title>attTn7 site Insertion</title><p id="P39">Introduction of DNA sequences to one or both <italic toggle="yes">att</italic>Tn7 sites was conducted according to previously described protocols (<xref rid="R31" ref-type="bibr">31</xref>) through mating between <italic toggle="yes">Bt</italic>E264, <italic toggle="yes">E. coli</italic> RHO3 carrying the Tn7 transposase-containing plasmid pTNS3, and <italic toggle="yes">E. coli</italic> RHO3 carrying a plasmid with DNA sequences for insertion. Mutants were confirmed with PCR analysis.</p></sec></sec><sec id="S19"><title>Efficient Biofilm Growth</title><p id="P40">Overnight cultures in LSLB were diluted to an OD<sub>600</sub> of 0.2 in 2ml of M63 within 14 mL polystyrene test tubes. Cultures were grown on a rotator at 37&#x000b0;C for 24 hours before imaging.</p></sec><sec id="S20"><title>Dynamic Biofilm Selection</title><p id="P41">Dynamic biofilm selection through serial passaging was conducted as described previously (<xref rid="R4" ref-type="bibr">4</xref>). Populations were initially composed of 2% Dup+ bacteria.</p></sec><sec id="S21"><title>Plate Reader Assay</title><p id="P42">Reporter strains were grown overnight in 2 mL LSLB at 37&#x000b0;C. Each culture was then diluted to 0.1 OD<sub>600</sub> in 2 mL M63 in polystyrene tubes and grown at 37&#x000b0;C. All planktonic cells and Dup+ cells contained within a biofilm were collected after 24 hours of growth. Strains locked as Dup&#x02212; were passaged daily with 2 mL M63 for 96 hours, at which point planktonic cells and cells contained within a biofilm were collected. At the time of collection, cells contained within a biofilm were washed off the sides of the tubes with 1 mL PBS. All cells were then washed in PBS twice and fixed with 2% paraformaldehyde.</p><p id="P43">A clear 96-well plate was used to measure the OD<sub>600</sub>, and a black 96-well plate was used to measure the absolute fluorescence intensity (AFI) at ex. 485 nm, em. 535 nm. Planktonic cells were added to each plate at a 1:10 dilution in PBS to a final volume of 200 &#x003bc;L, and 200 &#x003bc;L of cells recovered from the biofilm were added to each plate. The OD<sub>600</sub> and AFI of PBS were subtracted from the recorded values of each sample. The relative fluorescence intensities (RFI) were calculated by dividing the normalized AFI by the normalized OD<sub>600</sub> for each sample.</p></sec><sec id="S22"><title>Flow Cytometry</title><p id="P44">Fixed cells used in the plate reader assay were subsequently analyzed using flow cytometry. Each sample was stained with 0.05 mM SYTO<sup>&#x02122;</sup> 61 red fluorescent nucleic acid stain to distinguish cells from electronic noise and debris within the sample. Events positive for SYTO<sup>&#x02122;</sup> 61 were then used to determine the gating parameters for forward and side scatter to identify single cells. Analysis was performed with FlowJo software.</p></sec><sec id="S23"><title>Plasmids</title><table-wrap position="anchor" id="T1"><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Plasmid</th><th align="center" valign="middle" rowspan="1" colspan="1">Information</th><th align="center" valign="middle" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">pJET1.2</td><td align="left" valign="middle" rowspan="1" colspan="1">Common cloning vector. Ap<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7</td><td align="left" valign="middle" rowspan="1" colspan="1">Plasmid for delivering DNA fragments to <italic toggle="yes">att</italic>Tn7 sites. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pSM112</td><td align="left" valign="middle" rowspan="1" colspan="1">Suicide plasmid for <italic toggle="yes">Burkholderia</italic> with chloramphenicol resistance. Cm<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL79</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing 500 bp corresponding to the junction between IS&#x003b2; and subregion 1, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL89</td><td align="left" valign="middle" rowspan="1" colspan="1">pSM112 containing 500 bp corresponding to the junction between subregions 1 and 2, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Cm<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL80</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing 500 bp corresponding to the junction between subregions 1 and 2, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Ap<sup>R</sup>, Zeo<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL90</td><td align="left" valign="middle" rowspan="1" colspan="1">pSM112 containing 500 bp corresponding to the junction between subregions 2 and 3, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Cm<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL81</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing 500 bp corresponding to the junction between subregions 2 and 3, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL91</td><td align="left" valign="middle" rowspan="1" colspan="1">pSM112 containing 500 bp corresponding to the junction between subregions 3 and 4, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Cm<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL82</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7containing 500 bp corresponding to the junction between subregions 3 and 4, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Ap<sup>R</sup>, Zeo<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL92</td><td align="left" valign="middle" rowspan="1" colspan="1">pSM112 containing 500 bp corresponding to the junction between subregions 4 and 5, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Cm<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL83</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing 500 corresponding to the junction between subregions 4 and 5, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL93</td><td align="left" valign="middle" rowspan="1" colspan="1">pSM112 containing 500 bp corresponding to the junction between subregions 5 and 6, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Cm<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL84</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7containing 500 bp corresponding to the junction between subregions 5 and 6, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Ap<sup>R</sup>, Zeo<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL94</td><td align="left" valign="middle" rowspan="1" colspan="1">pSM112 containing 500 bp corresponding to the junction between subregions 6 and 7, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Cm<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL85</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing 500 bp corresponding to the junction between subregions 6 and 7, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL95</td><td align="left" valign="middle" rowspan="1" colspan="1">pSM112 containing 500 bp corresponding to the junction between subregions 7 and 8, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Cm<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL86</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing 500 bp corresponding to the junction between subregions 7 and 8, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Ap<sup>R</sup>, Zeo<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL96</td><td align="left" valign="middle" rowspan="1" colspan="1">pSM112 containing 500 bp corresponding to the junction between subregions 8 and 9, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Cm<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL87</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing 500 bp corresponding to the junction between subregions 8 and 9, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL97</td><td align="left" valign="middle" rowspan="1" colspan="1">pSM112 containing 500 bp corresponding to the junction between subregion 9 and 3&#x02019; to subregion 9 and IS&#x003b1;, with an I-<italic toggle="yes">Sce</italic>I restriction site at the 3&#x02019; end. Cm<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL98</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing subregion 1. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL99</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing subregion 2. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL100</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing subregion 3. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL101</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing subregion 4. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL102</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing subregion 5. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL103</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing subregion 6. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL104</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing subregion 7. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL105</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing subregion 8. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL106</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing subregion 9. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL111</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing sub-subregion 4.1. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL110</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing sub-subregion 4.2. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL109</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing sub-subregion 4.3. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL108</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing sub-subregion 4.4. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL107</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing sub-subregion 4.5. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL120</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing sub-subregions 4.4 and 4.5. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL113</td><td align="left" valign="middle" rowspan="1" colspan="1">pJET1.2 containing <italic toggle="yes">dhfRII</italic> flanked by 500 bp 5&#x02019; and 3&#x02019; to <italic toggle="yes">aplFABCDE</italic>. Ap<sup>R</sup>, Tmp<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL172</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing <italic toggle="yes">dhfRII</italic> flanked by 500 bp 5&#x02019; and 3&#x02019; to <italic toggle="yes">iou</italic>. Ap<sup>R</sup>, Tmp<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL112</td><td align="left" valign="middle" rowspan="1" colspan="1">pJET1.2 containing <italic toggle="yes">dhfRII</italic> flanked by 500 bp 5&#x02019; and 3&#x02019; to <italic toggle="yes">bubSR</italic>. Ap<sup>R</sup>, Tmp<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL119</td><td align="left" valign="middle" rowspan="1" colspan="1">pJET1.2 containing <italic toggle="yes">dhfRII</italic> flanked by 500&#x02019; bp 5&#x02019; and 3&#x02019; to <italic toggle="yes">aplFABCDE,iou,bubSR</italic>. Ap<sup>R</sup>, Tmp<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL162</td><td align="left" valign="middle" rowspan="1" colspan="1">pJET1.2 containing <italic toggle="yes">ble</italic> and <italic toggle="yes">gusA</italic><sub>1-1454</sub> (<italic toggle="yes">gusA</italic>&#x02019;) flanked by 500 bp corresponding to sequences immediately 5&#x02019; to <italic toggle="yes">aplF</italic>. Ap<sup>R</sup>, Zeo<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL161</td><td align="left" valign="middle" rowspan="1" colspan="1">pJET1.2 containing tet and <italic toggle="yes">gusA</italic><sub>118&#x02013;1691</sub> (&#x02019;<italic toggle="yes">gusA</italic>) flanked by 500 bp corresponding to sequences immediately 3&#x02019; to <italic toggle="yes">bubR</italic>. Ap<sup>R</sup>, Tc<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pEXKm5</td><td align="left" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">sacB</italic>-based allelic exchange plasmid. Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL144</td><td align="left" valign="middle" rowspan="1" colspan="1">pEXKm5 containing sequences to delete the entire <italic toggle="yes">bubS</italic> gene. Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL145</td><td align="left" valign="middle" rowspan="1" colspan="1">pEXKm5 containing sequences to delete the entire <italic toggle="yes">bubR</italic> gene. Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL143</td><td align="left" valign="middle" rowspan="1" colspan="1">pEXKm5 containing a 487 bp DNA fragment with codon 55 (CAG) replaced with the codon for alanine (GCT). Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pLL177</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC18-mini-Tn7 containing <italic toggle="yes">aplF</italic>&#x02019;-&#x02019;<italic toggle="yes">aplE,iou,bubSR</italic>. Ap<sup>R</sup>, Km<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pKBM19</td><td align="left" valign="middle" rowspan="1" colspan="1">pUC-18-mini-Tn7 derivative with <italic toggle="yes">nptII</italic> replaced with <italic toggle="yes">cat</italic> and a codon optimized <italic toggle="yes">gfp</italic> gene driven by P<sub>S12</sub>. Ap<sup>R</sup>, Cm<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pKBM21</td><td align="left" valign="middle" rowspan="1" colspan="1">pKBM19 derivative with P<sub>S12</sub> replaced with 570 bp 5&#x02019; to <italic toggle="yes">aplF</italic> (P<sub><italic toggle="yes">apl</italic></sub>). Ap<sup>R</sup>, Cm<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">pKBM20</td><td align="left" valign="middle" rowspan="1" colspan="1">pKBM19 derivative with P<sub>S12</sub> replaced with 527 bp 5&#x02019; to <italic toggle="yes">bubSR</italic> (P<sub><italic toggle="yes">bub</italic></sub>). Ap<sup>R</sup>, Cm<sup>R</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr></tbody></table></table-wrap></sec><sec id="S24"><title>Strains</title><table-wrap position="anchor" id="T2"><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Strain</th><th align="center" valign="middle" rowspan="1" colspan="1">Information</th><th align="center" valign="middle" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">E264</td><td align="left" valign="middle" rowspan="1" colspan="1">Wild-type <italic toggle="yes">B. thailandensis</italic> environmental isolate</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2;::<italic toggle="yes">nptII</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">Described previously</td><td align="left" valign="middle" rowspan="1" colspan="1">(<xref rid="R4" ref-type="bibr">4</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2;</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2;::<italic toggle="yes">nptII</italic> with <italic toggle="yes">nptII</italic> removed via Flp-RFT recombination</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain for isolating subregion 1</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL79 and pLL89 integrated into the chromosome</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain for isolating subregion 2</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL80 and pLL90 integrated into the chromosome</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain for isolating subregion 3</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL81 and pLL91 integrated into the chromosome</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain for isolating subregion 4</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL82 and pLL92 integrated into the chromosome</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain for isolating subregion 5</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL83 and pLL93 integrated into the chromosome</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain for isolating subregion 6</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL84 and pLL94 integrated into the chromosome</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain for isolating subregion 7</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL85 and pLL95 integrated into the chromosome</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain for isolating subregion 8</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL86 and pLL96 integrated into the chromosome</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain for isolating subregion 9</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL87 and pLL97 integrated into the chromosome</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of subregion 1</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL98 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of subregion 2</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL99 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of subregion 3</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL100 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of subregion 4</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL101 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of subregion 5</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL102 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of subregion 6</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL103 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of subregion 7</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL104 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of subregion 8</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL105 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of subregion 9</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL106 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of sub-subregion 4.1</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL111 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of sub-subregion 4.2</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL110 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of sub-subregion 4.3</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL109 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of sub-subregion 4.4</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL108 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of sub-subregion 4.5</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL107 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Strain with duplicate copies of sub-subregion 4.4 and sub-subregion 4.5</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL120 integrated into the chromosome at the native site</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain</td><td align="left" valign="middle" rowspan="1" colspan="1">Described previously</td><td align="left" valign="middle" rowspan="1" colspan="1">(<xref rid="R4" ref-type="bibr">4</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain &#x00394;<italic toggle="yes">aplFABCDE</italic>::<italic toggle="yes">dhfRII</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">The fragmented <italic toggle="yes">nptII</italic> reporter strain with <italic toggle="yes">aplFABCDE</italic> replaced with <italic toggle="yes">dhfRII</italic> using pLL113</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain &#x00394;<italic toggle="yes">iou</italic>::<italic toggle="yes">dhfRII</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">The fragmented <italic toggle="yes">nptII</italic> reporter strain with <italic toggle="yes">iou</italic> replaced with <italic toggle="yes">dhfRII</italic> using pLL172</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain &#x00394;<italic toggle="yes">bubSR</italic>::<italic toggle="yes">dhfRII</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">The fragmented <italic toggle="yes">nptII</italic> reporter strain with <italic toggle="yes">bubSR</italic> replaced with <italic toggle="yes">dhfRII</italic> using pLL112</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain &#x00394;<italic toggle="yes">aplFABCDE</italic>::<italic toggle="yes">dhfRII</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">The fragmented <italic toggle="yes">nptII</italic> reporter strain with <italic toggle="yes">aplFABCDE</italic> replaced with <italic toggle="yes">dhfRII</italic> using pLL113</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">The fragmented <italic toggle="yes">nptII</italic> reporter strain with <italic toggle="yes">aplFABCDE,iou,bubSR</italic> replaced with <italic toggle="yes">dhfRII</italic> using pLL119</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">gusA</italic> reporter strain</td><td align="left" valign="middle" rowspan="1" colspan="1">Described previously</td><td align="left" valign="middle" rowspan="1" colspan="1">(<xref rid="R4" ref-type="bibr">4</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">gusA</italic> reporter strain &#x00394;<italic toggle="yes">aplFABCDE</italic>::<italic toggle="yes">dhfRII</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">The fragmented <italic toggle="yes">gusA</italic> reporter strain with <italic toggle="yes">aplFABCDE</italic> replaced with <italic toggle="yes">dhfRII</italic> using pLL113</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">gusA</italic> reporter strain &#x00394;<italic toggle="yes">iou</italic>::<italic toggle="yes">dhfRII</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">The fragmented <italic toggle="yes">gusA</italic> reporter strain with <italic toggle="yes">iou</italic> replaced with <italic toggle="yes">dhfRII</italic> using pLL172</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">gusA</italic> reporter strain &#x00394;<italic toggle="yes">bubSR</italic>::<italic toggle="yes">dhfRII</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">The fragmented <italic toggle="yes">gusA</italic> reporter strain with <italic toggle="yes">bubSR</italic> replaced with <italic toggle="yes">dhfRII</italic> using pLL112</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">gusA</italic> reporter strain &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">The fragmented <italic toggle="yes">gusA</italic> reporter strain with <italic toggle="yes">aplFABCDE,iou,bubSR</italic> replaced with <italic toggle="yes">dhfRII</italic> using pLL119</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Reduced fragmented <italic toggle="yes">gusA</italic> reporter strain</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b2; with pLL162 and pLL161 integrated into the chromosome to flank <italic toggle="yes">aplFABCDE</italic> and <italic toggle="yes">bubSR</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain &#x00394;<italic toggle="yes">bubS</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">The fragmented <italic toggle="yes">nptII</italic> reporter strain with <italic toggle="yes">bubS</italic> deleted through allelic exchange with pLL144</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain &#x00394;<italic toggle="yes">bubR</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">The fragmented <italic toggle="yes">nptII</italic> reporter strain with <italic toggle="yes">bubR</italic> deleted through allelic exchange with pLL145</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain BubR<sub>D55A</sub></td><td align="left" valign="middle" rowspan="1" colspan="1">The fragmented <italic toggle="yes">nptII</italic> reporter strain with a D55A mutation introduced in <italic toggle="yes">bubR</italic> through allelic exchange with pLL143</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1;::<italic toggle="yes">nptII</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">Described previously</td><td align="left" valign="middle" rowspan="1" colspan="1">(<xref rid="R4" ref-type="bibr">4</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1;</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1;::<italic toggle="yes">nptII</italic> with <italic toggle="yes">nptII</italic> removed via Flp-RFT recombination</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">bubSR</italic>::<italic toggle="yes">dhfRII</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; with bubSR replaced with <italic toggle="yes">dhfRII</italic> using pLL112</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">bubSR</italic>::<italic toggle="yes">dhfRII att</italic>Tn7::<italic toggle="yes">iou,bubSR</italic> x1</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">bubSR</italic>::<italic toggle="yes">dhfRII</italic> with pLL107 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">bubSR</italic>::<italic toggle="yes">dhfRII att</italic>Tn7::<italic toggle="yes">iou,bubSR</italic> x2</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">bubSR</italic>::<italic toggle="yes">dhfRII</italic> with pLL107 inserted at <italic toggle="yes">glmS-1</italic>and <italic toggle="yes">glmS-2</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; with <italic toggle="yes">aplFABCDE,iou,bubSR</italic> replaced with <italic toggle="yes">dhfRII</italic> using pLL119</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII att</italic>Tn7::<italic toggle="yes">aplFABCDE,iou,bubSR</italic> x1</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic> with pLL120 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII att</italic>Tn7::<italic toggle="yes">aplFABCDE,iou,bubSR</italic> x2</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic> with pLL120 inserted at <italic toggle="yes">glmS-1</italic> and <italic toggle="yes">glmS-2</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">bubSR</italic>::<italic toggle="yes">dhfRII att</italic>Tn7::<italic toggle="yes">aplF</italic>&#x02018;-&#x02019;<italic toggle="yes">aplE,iou,bubSR</italic> x1</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">bubSR</italic>::<italic toggle="yes">dhfRII</italic> with pLL177 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">bubSR</italic>::<italic toggle="yes">dhfRII att</italic>Tn7::<italic toggle="yes">aplF</italic>&#x02018;-&#x02019;<italic toggle="yes">aplE,iou,bubSR</italic> x2</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">bubSR</italic>::<italic toggle="yes">dhfRII</italic> with pLL177 inserted at <italic toggle="yes">glmS-1</italic>and <italic toggle="yes">glmS-2</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; P<sub>apl</sub>-<italic toggle="yes">gfp</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; with pKBM21 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain P<sub><italic toggle="yes">apl</italic></sub>-<italic toggle="yes">gfp</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain with pKBM21 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; BubR<sub>D55A</sub></td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; with a D55A mutation introduced in <italic toggle="yes">bubR</italic> through allelic exchange with pLL143</td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; BubR<sub>D55A</sub> P<sub><italic toggle="yes">apl</italic></sub>-<italic toggle="yes">gfp</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; BubR<sub>D55A</sub> with pKBM21 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain BubR<sub>D55A</sub> P<sub><italic toggle="yes">apl</italic></sub>-<italic toggle="yes">gfp</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain BubR<sub>D55A</sub> with pKBM21 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic> P<sub><italic toggle="yes">apl</italic></sub>-<italic toggle="yes">gfp</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic> with pKBM21 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic> P<sub><italic toggle="yes">apl</italic></sub>-<italic toggle="yes">gfp</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic> with pKBM21 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; P<sub><italic toggle="yes">bub</italic></sub>-<italic toggle="yes">gfp</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; with pKBM20 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain P<sub><italic toggle="yes">bub</italic></sub>-<italic toggle="yes">gfp</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain with pKBM20 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; BubR<sub>D55A</sub> P<sub><italic toggle="yes">bub</italic></sub>-<italic toggle="yes">gfp</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; BubR<sub>D55A</sub> with pKBM20 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain BubR<sub>D55A</sub> P<sub><italic toggle="yes">bub</italic></sub>-gfp</td><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain BubR<sub>D55A</sub> with pKBM20 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic> P<sub><italic toggle="yes">bub</italic></sub>-<italic toggle="yes">gfp</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;IS&#x003b1; &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic> with pKBM20 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR::dhfRII</italic> P<sub><italic toggle="yes">bub</italic></sub>-<italic toggle="yes">gfp</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">Fragmented <italic toggle="yes">nptII</italic> reporter strain &#x00394;<italic toggle="yes">aplFABCDE,iou,bubSR</italic>::<italic toggle="yes">dhfRII</italic> with pKBM20 inserted at <italic toggle="yes">glmS-1</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">This study</td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>Supplement 1</label><media xlink:href="NIHPP2024.12.09.627470v1-supplement-1.pdf" id="d67e3084" position="anchor"/></supplementary-material></sec></body><back><ack id="S25"><title>Acknowledgements</title><p id="P45">The UNC Flow Cytometry Core Facility (RRID:SCR_019170) is supported in part by P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center. We thank members of the Cotter Lab, especially Bridgett Rios, for helpful discussions.</p></ack><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Brett</surname><given-names>PJ</given-names></name>, <name><surname>DeShazer</surname><given-names>D</given-names></name>, <name><surname>Woods</surname><given-names>DE</given-names></name>. <article-title>Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species</article-title>. <source>Int J Syst Bacteriol</source>. <year>1998</year>
<month>Jan</month>;<volume>48</volume>
<comment>Pt 1</comment>:<fpage>317</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">9542103</pub-id>
</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Nierman</surname><given-names>WC</given-names></name>, <name><surname>DeShazer</surname><given-names>D</given-names></name>, <name><surname>Kim</surname><given-names>HS</given-names></name>, <name><surname>Tettelin</surname><given-names>H</given-names></name>, <name><surname>Nelson</surname><given-names>KE</given-names></name>, <name><surname>Feldblyum</surname><given-names>T</given-names></name>, <etal/>
<article-title>Structural flexibility in the Burkholderia mallei genome</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2004</year>
<month>Sep</month>
<day>28</day>;<volume>101</volume>(<issue>39</issue>):<fpage>14246</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">15377793</pub-id>
</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Ocasio</surname><given-names>AB</given-names></name>, <name><surname>Cotter</surname><given-names>PA</given-names></name>. <article-title>CDI/CDS system-encoding genes of Burkholderia thailandensis are located in a mobile genetic element that defines a new class of transposon</article-title>. <source>PLoS Genet</source>. <year>2019</year>;<volume>15</volume>(<issue>1</issue>):<fpage>e1007883</fpage>.<pub-id pub-id-type="pmid">30615607</pub-id>
</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Lowrey</surname><given-names>LC</given-names></name>, <name><surname>Kent</surname><given-names>LA</given-names></name>, <name><surname>Rios</surname><given-names>BM</given-names></name>, <name><surname>Ocasio</surname><given-names>AB</given-names></name>, <name><surname>Cotter</surname><given-names>PA</given-names></name>. <article-title>An IS-mediated, RecA-dependent, bet-hedging strategy in Burkholderia thailandensis</article-title>. <source>eLife</source>. <year>2023</year>
<month>Jan</month>
<day>30</day>;<volume>12</volume>:<fpage>e84327</fpage>.<pub-id pub-id-type="pmid">36715687</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Andersson</surname><given-names>DI</given-names></name>, <name><surname>Hughes</surname><given-names>D</given-names></name>. <article-title>Gene amplification and adaptive evolution in bacteria</article-title>. <source>Annu Rev Genet</source>. <year>2009</year>;<volume>43</volume>:<fpage>167</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">19686082</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Sandegren</surname><given-names>L</given-names></name>, <name><surname>Andersson</surname><given-names>DI</given-names></name>. <article-title>Bacterial gene amplification: implications for the evolution of antibiotic resistance</article-title>. <source>Nat Rev Microbiol</source>. <year>2009</year>
<month>Aug</month>;<volume>7</volume>(<issue>8</issue>):<fpage>578</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="pmid">19609259</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Capra</surname><given-names>EJ</given-names></name>, <name><surname>Laub</surname><given-names>MT</given-names></name>. <article-title>Evolution of Two-Component Signal Transduction Systems</article-title>. <source>Annual Review of Microbiology</source>. <year>2012</year>
<month>Oct</month>
<day>13</day>;<volume>66</volume>(Volume <comment>66</comment>, <issue>2012</issue>):<fpage>325</fpage>&#x02013;<lpage>47</lpage>.</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Morawska</surname><given-names>LP</given-names></name>, <name><surname>Hernandez-Valdes</surname><given-names>JA</given-names></name>, <name><surname>Kuipers</surname><given-names>OP</given-names></name>. <article-title>Diversity of bet-hedging strategies in microbial communities-Recent cases and insights. WIREs Mech Dis</article-title>. <year>2022</year>
<source>Mar</source>;<volume>14</volume>(<issue>2</issue>):<fpage>e1544</fpage>.</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>van der Woude</surname><given-names>MW</given-names></name>. <article-title>Phase variation: how to create and coordinate population diversity</article-title>. <source>Curr Opin Microbiol</source>. <year>2011</year>
<month>Apr</month>;<volume>14</volume>(<issue>2</issue>):<fpage>205</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">21292543</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Carey</surname><given-names>JN</given-names></name>, <name><surname>Goulian</surname><given-names>M</given-names></name>. <article-title>A bacterial signaling system regulates noise to enable bet hedging</article-title>. <source>Curr Genet</source>. <year>2019</year>
<month>Feb</month>;<volume>65</volume>(<issue>1</issue>):<fpage>65</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">29947971</pub-id>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Carey</surname><given-names>JN</given-names></name>, <name><surname>Mettert</surname><given-names>EL</given-names></name>, <name><surname>Roggiani</surname><given-names>M</given-names></name>, <name><surname>Myers</surname><given-names>KS</given-names></name>, <name><surname>Kiley</surname><given-names>PJ</given-names></name>, <name><surname>Goulian</surname><given-names>M</given-names></name>. <article-title>Regulated Stochasticity in a Bacterial Signaling Network Permits Tolerance to a Rapid Environmental Change</article-title>. <source>Cell</source>. <year>2018</year>
<month>Mar</month>
<day>22</day>;<volume>173</volume>(<issue>1</issue>):<fpage>196</fpage>&#x02013;<lpage>207.e14</lpage>.<pub-id pub-id-type="pmid">29502970</pub-id>
</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Tuanyok</surname><given-names>A</given-names></name>, <name><surname>Tom</surname><given-names>M</given-names></name>, <name><surname>Dunbar</surname><given-names>J</given-names></name>, <name><surname>Woods</surname><given-names>DE</given-names></name>. <article-title>Genome-wide expression analysis of Burkholderia pseudomallei infection in a hamster model of acute melioidosis</article-title>. <source>Infect Immun</source>. <year>2006</year>
<month>Oct</month>;<volume>74</volume>(<issue>10</issue>):<fpage>5465</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">16988221</pub-id>
</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Tuanyok</surname><given-names>A</given-names></name>, <name><surname>Kim</surname><given-names>HS</given-names></name>, <name><surname>Nierman</surname><given-names>WC</given-names></name>, <name><surname>Yu</surname><given-names>Y</given-names></name>, <name><surname>Dunbar</surname><given-names>J</given-names></name>, <name><surname>Moore</surname><given-names>RA</given-names></name>, <etal/>
<article-title>Genome-wide expression analysis of iron regulation in Burkholderia pseudomallei and Burkholderia mallei using DNA microarrays</article-title>. <source>FEMS Microbiol Lett</source>. <year>2005</year>
<month>Nov</month>
<day>15</day>;<volume>252</volume>(<issue>2</issue>):<fpage>327</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">16242861</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Tabunhan</surname><given-names>S</given-names></name>, <name><surname>Wongratanacheewin</surname><given-names>S</given-names></name>, <name><surname>Wongwajana</surname><given-names>S</given-names></name>, <name><surname>Welbat</surname><given-names>TU</given-names></name>, <name><surname>Faksri</surname><given-names>K</given-names></name>, <name><surname>Namwat</surname><given-names>W</given-names></name>. <article-title>Characterization of a novel two-component system response regulator involved in biofilm formation and a low-iron response of Burkholderia pseudomallei</article-title>. <source>Southeast Asian J Trop Med Public Health</source>. <year>2014</year>
<month>Sep</month>;<volume>45</volume>(<issue>5</issue>):<fpage>1065</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="pmid">25417508</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Garcia</surname><given-names>EC</given-names></name>, <name><surname>Perault</surname><given-names>AI</given-names></name>, <name><surname>Marlatt</surname><given-names>SA</given-names></name>, <name><surname>Cotter</surname><given-names>PA</given-names></name>. <article-title>Interbacterial signaling via Burkholderia contact-dependent growth inhibition system proteins</article-title>. <source>PNAS</source>. <year>2016</year>
<month>Jul</month>
<day>19</day>;<volume>113</volume>(<issue>29</issue>):<fpage>8296</fpage>&#x02013;<lpage>301</lpage>.<pub-id pub-id-type="pmid">27335458</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Richardson</surname><given-names>AR</given-names></name>, <name><surname>Stojiljkovic</surname><given-names>I</given-names></name>. <article-title>HmbR, a Hemoglobin-Binding Outer Membrane Protein of Neisseria meningitidis, Undergoes Phase Variation</article-title>. <source>J Bacteriol</source>. <year>1999</year>
<month>Apr</month>;<volume>181</volume>(<issue>7</issue>):<fpage>2067</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">10094683</pub-id>
</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Lewis</surname><given-names>LA</given-names></name>, <name><surname>Gipson</surname><given-names>M</given-names></name>, <name><surname>Hartman</surname><given-names>K</given-names></name>, <name><surname>Ownbey</surname><given-names>T</given-names></name>, <name><surname>Vaughn</surname><given-names>J</given-names></name>, <name><surname>Dyer</surname><given-names>DW</given-names></name>. <article-title>Phase variation of HpuAB and HmbR, two distinct haemoglobin receptors of Neisseria meningitidis DNM2</article-title>. <source>Mol Microbiol</source>. <year>1999</year>
<month>Jun</month>;<volume>32</volume>(<issue>5</issue>):<fpage>977</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="pmid">10361300</pub-id>
</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Goodwin</surname><given-names>AC</given-names></name>, <name><surname>Weinberger</surname><given-names>DM</given-names></name>, <name><surname>Ford</surname><given-names>CB</given-names></name>, <name><surname>Nelson</surname><given-names>JC</given-names></name>, <name><surname>Snider</surname><given-names>JD</given-names></name>, <name><surname>Hall</surname><given-names>JD</given-names></name>, <etal/>
<article-title>Expression of the Helicobacter pylori adhesin SabA is controlled via phase variation and the ArsRS signal transduction system</article-title>. <source>Microbiology</source>. <year>2008</year>;<volume>154</volume>(<issue>8</issue>):<fpage>2231</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">18667556</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Acio-Pizzarello</surname><given-names>CR</given-names></name>, <name><surname>Acio</surname><given-names>AA</given-names></name>, <name><surname>Choi</surname><given-names>EJ</given-names></name>, <name><surname>Bond</surname><given-names>K</given-names></name>, <name><surname>Kim</surname><given-names>J</given-names></name>, <name><surname>Kenan</surname><given-names>AC</given-names></name>, <etal/>
<article-title>Determinants of the regulation of Helicobacter pylori adhesins include repeat sequences in both promoter and coding regions as well as the two-component system ArsRS</article-title>. <source>Journal of Medical Microbiology</source>. <year>2017</year>;<volume>66</volume>(<issue>6</issue>):<fpage>798</fpage>&#x02013;<lpage>807</lpage>.<pub-id pub-id-type="pmid">28598306</pub-id>
</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Talarico</surname><given-names>S</given-names></name>, <name><surname>Whitefield</surname><given-names>SE</given-names></name>, <name><surname>Fero</surname><given-names>J</given-names></name>, <name><surname>Haas</surname><given-names>R</given-names></name>, <name><surname>Salama</surname><given-names>NR</given-names></name>. <article-title>Regulation of Helicobacter pylori adherence by gene conversion</article-title>. <source>Molecular Microbiology</source>. <year>2012</year>;<volume>84</volume>(<issue>6</issue>):<fpage>1050</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">22519812</pub-id>
</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Stibitz</surname><given-names>S</given-names></name>, <name><surname>Aaronson</surname><given-names>W</given-names></name>, <name><surname>Monack</surname><given-names>D</given-names></name>, <name><surname>Falkow</surname><given-names>S</given-names></name>. <article-title>Phase variation in Bordetella pertussis by frameshift mutation in a gene for a novel two-component system</article-title>. <source>Nature</source>. <year>1989</year>
<month>Mar</month>
<day>16</day>;<volume>338</volume>(<issue>6212</issue>):<fpage>266</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">2537932</pub-id>
</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Hendrixson</surname><given-names>DR</given-names></name>. <article-title>A phase-variable mechanism controlling the Campylobacter jejuni FlgR response regulator influences commensalism</article-title>. <source>Mol Microbiol</source>. <year>2006</year>
<month>Sep</month>;<volume>61</volume>(<issue>6</issue>):<fpage>1646</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="pmid">16899076</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>P&#x000e9;rez-Varela</surname><given-names>M</given-names></name>, <name><surname>Tierney</surname><given-names>ARP</given-names></name>, <name><surname>Dawson</surname><given-names>E</given-names></name>, <name><surname>Hutcheson</surname><given-names>AR</given-names></name>, <name><surname>Tipton</surname><given-names>KA</given-names></name>, <name><surname>Anderson</surname><given-names>SE</given-names></name>, <etal/>
<article-title>Stochastic activation of a family of TetR type transcriptional regulators controls phenotypic heterogeneity in Acinetobacter baumannii</article-title>. <source>PNAS Nexus</source>. <year>2022</year>
<month>Nov</month>
<day>1</day>;<volume>1</volume>(<issue>5</issue>):<fpage>pgac231</fpage>.<pub-id pub-id-type="pmid">36704122</pub-id>
</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>B</given-names></name>, <name><surname>Pain</surname><given-names>A</given-names></name>, <name><surname>Johnstone</surname><given-names>K</given-names></name>. <article-title>Spontaneous duplication of a 661 bp element within a two-component sensor regulator gene causes phenotypic switching in colonies of Pseudomonas tolaasii, cause of brown blotch disease of mushrooms</article-title>. <source>Mol Microbiol</source>. <year>1997</year>
<month>Jul</month>;<volume>25</volume>(<issue>2</issue>):<fpage>211</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">9282733</pub-id>
</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>S&#x000e1;nchez-Contreras</surname><given-names>M</given-names></name>, <name><surname>Mart&#x000ed;n</surname><given-names>M</given-names></name>, <name><surname>Villacieros</surname><given-names>M</given-names></name>, <name><surname>O&#x02019;Gara</surname><given-names>F</given-names></name>, <name><surname>Bonilla</surname><given-names>I</given-names></name>, <name><surname>Rivilla</surname><given-names>R</given-names></name>. <article-title>Phenotypic Selection and Phase Variation Occur during Alfalfa Root Colonization by Pseudomonas fluorescens F113</article-title>. <source>J Bacteriol</source>. <year>2002</year>
<month>Mar</month>;<volume>184</volume>(<issue>6</issue>):<fpage>1587</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">11872710</pub-id>
</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Lalaouna</surname><given-names>D</given-names></name>, <name><surname>Fochesato</surname><given-names>S</given-names></name>, <name><surname>Sanchez</surname><given-names>L</given-names></name>, <name><surname>Schmitt-Kopplin</surname><given-names>P</given-names></name>, <name><surname>Haas</surname><given-names>D</given-names></name>, <name><surname>Heulin</surname><given-names>T</given-names></name>, <etal/>
<article-title>Phenotypic Switching in Pseudomonas brassicacearum Involves GacS- and GacA-Dependent Rsm Small RNAs</article-title>. <source>Appl Environ Microbiol</source>. <year>2012</year>
<month>Mar</month>;<volume>78</volume>(<issue>6</issue>):<fpage>1658</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">22247157</pub-id>
</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>L&#x000f3;pez</surname><given-names>CM</given-names></name>, <name><surname>Rholl</surname><given-names>DA</given-names></name>, <name><surname>Trunck</surname><given-names>LA</given-names></name>, <name><surname>Schweizer</surname><given-names>HP</given-names></name>. <article-title>Versatile Dual-Technology System for Markerless Allele Replacement in Burkholderia pseudomallei</article-title>. <source>Appl Environ Microbiol</source>. <year>2009</year>
<month>Oct</month>;<volume>75</volume>(<issue>20</issue>):<fpage>6496</fpage>&#x02013;<lpage>503</lpage>.<pub-id pub-id-type="pmid">19700544</pub-id>
</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Okada</surname><given-names>BK</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Mao</surname><given-names>D</given-names></name>, <name><surname>Bushin</surname><given-names>LB</given-names></name>, <name><surname>Seyedsayamdost</surname><given-names>MR</given-names></name>. <article-title>Mapping the Trimethoprim-Induced Secondary Metabolome of Burkholderia thailandensis</article-title>. <source>ACS Chem Biol</source>. <year>2016</year>
<month>Aug</month>
<day>19</day>;<volume>11</volume>(<issue>8</issue>):<fpage>2124</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">27367535</pub-id>
</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Thongdee</surname><given-names>M</given-names></name>, <name><surname>Gallagher</surname><given-names>LA</given-names></name>, <name><surname>Schell</surname><given-names>M</given-names></name>, <name><surname>Dharakul</surname><given-names>T</given-names></name>, <name><surname>Songsivilai</surname><given-names>S</given-names></name>, <name><surname>Manoil</surname><given-names>C</given-names></name>. <article-title>Targeted Mutagenesis of Burkholderia thailandensis and Burkholderia pseudomallei through Natural Transformation of PCR Fragments</article-title>. <source>Appl Environ Microbiol</source>. <year>2008</year>
<month>May</month>;<volume>74</volume>(<issue>10</issue>):<fpage>2985</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">18310423</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>KH</given-names></name>, <name><surname>Mima</surname><given-names>T</given-names></name>, <name><surname>Casart</surname><given-names>Y</given-names></name>, <name><surname>Rholl</surname><given-names>D</given-names></name>, <name><surname>Kumar</surname><given-names>A</given-names></name>, <name><surname>Beacham</surname><given-names>IR</given-names></name>, <etal/>
<article-title>Genetic Tools for Select-Agent-Compliant Manipulation of Burkholderia pseudomallei</article-title>. <source>Appl Environ Microbiol</source>. <year>2008</year>
<month>Feb</month>;<volume>74</volume>(<issue>4</issue>):<fpage>1064</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">18156318</pub-id>
</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>KH</given-names></name>, <name><surname>Gaynor</surname><given-names>JB</given-names></name>, <name><surname>White</surname><given-names>KG</given-names></name>, <name><surname>Lopez</surname><given-names>C</given-names></name>, <name><surname>Bosio</surname><given-names>CM</given-names></name>, <name><surname>Karkhoff-Schweizer</surname><given-names>RR</given-names></name>, <etal/>
<article-title>A Tn7-based broad-range bacterial cloning and expression system</article-title>. <source>Nat Methods</source>. <year>2005</year>
<month>Jun</month>;<volume>2</volume>(<issue>6</issue>):<fpage>443</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">15908923</pub-id>
</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1:</label><caption><title>Duplicate copies of a subregion of DNA containing <italic toggle="yes">aplFABCDE, iou, and bubSR,</italic> is sufficient to promote efficient biofilm formation.</title><p id="P46">(A) Top: Schematic of the duplicating region divided into nine subregions. Subregion boundaries were designed to prevent interruption of coding sequences or separation of coding sequences from their putative promoters. Bottom: Images of overnight cultures comparing the biofilm-forming ability of wild-type <italic toggle="yes">B</italic>tE264 to strains with duplicate copies of subregions 1 &#x02013; 9. (B) Top: Schematic of the fourteen predicted genes located within subregion 4 and the boundaries of sub-subregions 4.1 &#x02013; 4.5. Bottom: Images of overnight cultures comparing the biofilm-forming ability of wild-type <italic toggle="yes">Bt</italic>E264 and a strain with a duplicate copy of subregion 4 to strains with duplicate copies of sub-subregions 4.1 &#x02013; 4.5 and 4.4&#x02013;5.</p></caption><graphic xlink:href="nihpp-2024.12.09.627470v1-f0001" position="float"/></fig><fig position="float" id="F2"><label>Figure 2:</label><caption><title><italic toggle="yes">aplFABCDE</italic> and <italic toggle="yes">bubSR</italic> are required for efficient biofilm formation.</title><p id="P47">(A) Schematic of the fragmented <italic toggle="yes">nptII</italic> gene system used to duplicate the 208.6 kb region in strains lacking sequences of interest, such as <italic toggle="yes">bubSR</italic>, to test requirements for efficient biofilm formation. Genes of interest were replaced with <italic toggle="yes">dhfRII</italic> in a Dup&#x02212; (Km<sup>S</sup>) fragmented <italic toggle="yes">nptII</italic> reporter stain. Using kanamycin selection, cells that had spontaneously duplicated the region could be isolated. (B) Images of overnight cultures comparing the biofilm forming ability of fragmented <italic toggle="yes">nptII</italic> strains with deletions of <italic toggle="yes">aplFABCDE</italic>, <italic toggle="yes">iou</italic>, and/or <italic toggle="yes">bubSR</italic> with and without duplicate copies of the 208.6 kb region.</p></caption><graphic xlink:href="nihpp-2024.12.09.627470v1-f0002" position="float"/></fig><fig position="float" id="F3"><label>Figure 3:</label><caption><title><italic toggle="yes">aplFABCDE</italic> and <italic toggle="yes">bubSR</italic> are sufficient and required for duplication to provide a selective advantage during biofilm growth.</title><p id="P48">(A) Images of culture tube biofilms following two, four, and six days of serial biofilm passage of the fragmented <italic toggle="yes">gusA</italic> reporter strains that are otherwise wild-type or have <italic toggle="yes">aplFABCDE</italic>, <italic toggle="yes">iou</italic>, and/or <italic toggle="yes">bubSR</italic> deleted through replacement with <italic toggle="yes">dhfRII.</italic> Graph of the percentage of blue colonies grown from cells scraped from the edge of the culture tube daily during a seven-day serial biofilm passage experiment comparing (B) standard fragmented <italic toggle="yes">gusA</italic> reporter strains lacking <italic toggle="yes">aplFABCDE, iou</italic>, and/or <italic toggle="yes">bubSR</italic>, and (D) the standard and reduced fragmented <italic toggle="yes">gusA</italic> reporter strains. (C) Schematic of the fragmented <italic toggle="yes">gusA</italic> reporter strains wherein homologous recombination duplicates the entire 208.6 kb region (Standard) or just the 9.8 kb subregion containing <italic toggle="yes">aplFABCDE,iou,bubSR</italic> (Reduced).</p></caption><graphic xlink:href="nihpp-2024.12.09.627470v1-f0003" position="float"/></fig><fig position="float" id="F4"><label>Figure 4:</label><caption><title>BubSR TCS activity is required for efficient biofilm formation.</title><p id="P49">(A) Schematic of the BubS and BubR proteins including predicted domains identified by SMART and AlphaFold2 (denoted with *). Amino acids involved in phosphoryl relay are denoted. (B) AlphaFold2 structure of BubS<sub>E556-S680</sub>. The structure is colored according to per-residue predicted local distance difference test (pLDDT) scores that quantify structure confidence. (C) AlphaFold2 structure of BubS<sub>E556-S680</sub> overlaid with the <italic toggle="yes">E. coli</italic> BarA HPt domain (3IQT). (D) Images of overnight cultures comparing the biofilm forming ability of wild-type and <italic toggle="yes">bubSR</italic>::<italic toggle="yes">dhfRII</italic>, &#x00394;<italic toggle="yes">bubS</italic>, &#x00394;<italic toggle="yes">bubR</italic>, and BubR<sub>D55A</sub> mutants in a fragmented <italic toggle="yes">nptII</italic> background strain with and without duplicate copies of the 208.6 kb region.</p></caption><graphic xlink:href="nihpp-2024.12.09.627470v1-f0004" position="float"/></fig><fig position="float" id="F5"><label>Figure 5:</label><caption><title>Two copies of <italic toggle="yes">bubSR</italic> plus the intergenic region 5&#x002b9; to <italic toggle="yes">aplFABCDE</italic> are sufficient to promote efficient biofilm formation.</title><p id="P50">(A) Top: Schematic of strains with <italic toggle="yes">bubSR</italic> replaced with <italic toggle="yes">dhfRII</italic> and with <italic toggle="yes">bubSR</italic> inserted at either one, both, or neither <italic toggle="yes">att</italic>Tn<italic toggle="yes">7</italic> site. Bottom: Images of overnight cultures. (B) Top: Schematic of strains with <italic toggle="yes">aplFABCDE,iou,bubSR</italic> replaced with <italic toggle="yes">dhfRII</italic> and with <italic toggle="yes">aplFABCDE,iou,bubSR</italic> inserted at either one, both, or neither <italic toggle="yes">att</italic>Tn<italic toggle="yes">7</italic> site. Bottom: Images of overnight cultures. (C) Top: Schematic of strains with <italic toggle="yes">bubSR</italic> replaced with <italic toggle="yes">dhfRII</italic> and with <italic toggle="yes">aplF</italic>&#x002b9;&#x02212;&#x002b9;<italic toggle="yes">aplE,iou,bubSR</italic> inserted at either one, both, or neither <italic toggle="yes">att</italic>Tn<italic toggle="yes">7</italic> site. Bottom: Images of overnight cultures.</p></caption><graphic xlink:href="nihpp-2024.12.09.627470v1-f0005" position="float"/></fig><fig position="float" id="F6"><label>Figure 6:</label><caption><title>The intergenic region 5&#x002b9; to <italic toggle="yes">aplF</italic>, but not the region between <italic toggle="yes">aplE</italic> and <italic toggle="yes">bubS</italic>, contains a promoter that is activated during biofilm growth and when the 208.6 kb region is duplicated, in a <italic toggle="yes">bubSR</italic>-dependent manner.</title><p id="P51">(A) Schematic of subregion 4 with putative <italic toggle="yes">apl</italic> and <italic toggle="yes">bub</italic> promoter regions used for construction of promoter-<italic toggle="yes">gfp</italic> fusions indicated. (B) Relative fluorescence intensity of the indicated strains containing the P<sub><italic toggle="yes">apl</italic></sub>-<italic toggle="yes">gfp</italic> fusion after 24- or 96-hours growth. P = planktonic, BF = biofilm. (C) Relative fluorescence intensity of the indicated strains containing the P<sub><italic toggle="yes">bub</italic></sub>-<italic toggle="yes">gfp</italic> fusion after 24- or 96-hours growth. P = planktonic, BF = biofilm.</p></caption><graphic xlink:href="nihpp-2024.12.09.627470v1-f0006" position="float"/></fig><fig position="float" id="F7"><label>Figure 7:</label><caption><title>Duplication of <italic toggle="yes">bubSR</italic> is sufficient for positive autoregulation in a majority of bacteria growing in M63 medium.</title><p id="P52">(A) Legend for the graphs shown in B&#x02013;F. P = planktonic, BF = biofilm. (B-F) Graphs showing fluorescence of populations of bacteria as indicated by the legend. The level of fluorescence is plotted along the X-axis on a log scale, and the number of bacteria, normalized to unit area under each curve so that different samples can be compared, is plotted along the Y-axis.</p></caption><graphic xlink:href="nihpp-2024.12.09.627470v1-f0007" position="float"/></fig></floats-group></article>